Auxilium (AUXL +0.9%) ticks higher after BofA Merrill Lynch ups its price target on the shares...

|About: Auxilium Pharmaceuticals, Inc. (AUXL)|By:, SA News Editor

Auxilium (AUXL +0.9%) ticks higher after BofA Merrill Lynch ups its price target on the shares to $28 from $24 on the back of yesterday's positive Phase 3 results of Xiaflex in fighting Peyronie's disease.